Clinical Trial Update: Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating switching HIV-1 patients from nevirapine immediate-release to extended-release regimens; results completed and posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• nevirapine extended-release (nevirapine)
• nevirapine immediate-release (nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-02-24